XML 66 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Revision of Immaterial Misstatements (Tables)
12 Months Ended
Dec. 31, 2022
Revision of Immaterial Misstatements  
Schedule of revision of financial statements

    

    

Year Ended

December 31, 2021

    

    

As reported

Adjustment

    

As revised

(in thousands)

 

 

  

 

  

Research and license revenue

 

$

5,000

$

350

$

5,350

Total revenue

 

$

5,000

$

350

$

5,350

Research and development expenses

 

$

(37,193)

$

248

$

(36,945)

General and administrative expenses

 

$

(12,160)

$

142

$

(12,018)

Total operating expenses

 

$

(49,353)

$

390

$

(48,963)

Operating loss

 

$

(44,353)

$

740

$

(43,613)

Foreign currency exchange gain (loss), net

 

$

(212)

$

2,252

$

2,040

Total non-operating income (loss)

 

$

(837)

$

2,252

$

1,415

Loss before income tax

 

$

(45,190)

$

2,992

$

(42,198)

Loss for the year

 

$

(45,347)

$

2,992

$

(42,355)

Foreign currency translation adjustment

 

$

(6,210)

$

568

$

(5,642)

Total comprehensive loss

 

$

(51,557)

$

3,560

$

(47,997)

    

    

Year Ended

December 31, 2020

    

    

As reported

Adjustment

    

As revised

(in thousands)

 

 

  

 

  

Research and license revenue

 

$

3,500

$

247

$

3,747

Total revenue

 

$

3,500

$

247

$

3,747

Operating loss

 

$

(14,920)

$

247

$

(14,673)

Foreign currency exchange gain (loss), net

 

$

(201)

$

(668)

$

(869)

Total non-operating income (loss)

 

$

(543)

$

(668)

$

(1,211)

Loss before income tax

 

$

(15,463)

$

(421)

$

(15,884)

Loss for the year

 

$

(15,506)

$

(421)

$

(15,927)

Foreign currency translation adjustment

 

$

(577)

$

375

$

(202)

Total comprehensive loss

 

$

(16,083)

$

(46)

$

(16,129)

In the Consolidated Statements of Financial Position and Changes in Equity, we have revised the following:

    

    

    

December 31, 2021

December 31, 2020

As reported

Adjustment

    

As revised

    

As reported

Adjustment

    

As revised

(in thousands)

Equity-settled employee benefits reserve

$

5,219

(390)

4,829

922

922

Foreign currency translation reserve

$

(4,042)

$

(2,181)

$

(6,223)

$

(1,003)

$

421

$

(581)

Accumulated deficit

$

(78,733)

$

2,571

$

(76,162)

$

(33,386)

$

(421)

$

(33,807)

Equity:

$

118,367

$

$

118,367

$

7,622

$

$

7,622

 

 

 

  

 

  

In the Consolidated Statements of Cash Flows, we have revised the following:

    

    

Year Ended

December 31, 2021

    

    

As reported

Adjustment

    

As revised

(in thousands)

Loss before income tax

$

(45,190)

$

2,992

$

(42,198)

Foreign currency exchange gain (loss), net

$

562

$

(2,602)

$

(2,040)

Share-based compensation expense

$

4,297

$

(390)

$

3,907

Cash and cash equivalents at end of year

$

90,869

$

$

90,869

    

    

Year Ended

December 31, 2020

    

    

As reported

Adjustment

    

As revised

(in thousands)

Loss before income tax

$

(15,463)

$

(421)

$

(15,884)

Foreign currency exchange gain (loss), net

$

448

$

421

$

869

Cash and cash equivalents at end of year

$

15,818

$

$

15,818